Oral semaglutide and change in cardiovascular risk factors in high-risk type 2 diabetes: a post hoc secondary analysis of the SOUL randomized clinical trial
Mulvagh SL, Inzucchi SE, Marx N, et al.
JAMA Cardiol. Pub. Online 25 Mar 2026.
Leggi
Quality-score (Q-Score) can be more sensitive than %time in range and several other CGM metrics in detecting responses to therapeutic interventions
Rodbard D, Augstein P, Heinke P, et al.
Diabetes Technol Ther. Pub. Online 27 Mar 2026.
Leggi
Per- and polyfluoroalkyl substances during pregnancy and gestational diabetes: the environmental influences on child health outcomes (ECHO) cohort
Starling AP, Burjak M, Nzegwu AW, et al.
Diabetes Care. Pub. Online 24 Mar 2026.
Leggi
Profiles of social determinants of health and change in diabetes status among U.S. hispanic/latino adults: HCHS/SOL, 2008–2024
Brown CJ, Roesch SC, Rosas CE, et al.
Diabetes Care. Pub. Online 24 Mar 2026.
Leggi
Mechanisms of GLP-1 receptor agonists in HFpEF: exploring weight-dependent and independent drivers of therapeutic benefit
Thomas J, Dagan M, Wang B, Gutman S, et al.
Circ Heart Fail. Pub. Online 25 Mar 2026.
Leggi
Glucagon-like peptide-1 receptor agonists and heart failure hospitalization in a real-world cardiometabolic population
Issaka Y, Abdul-Kareem H, Meyahnwi D, et al.
Am J Cardiol. Pub. Online 25 Mar 2026.
Leggi
Continuous glucose monitoring and risks of acute and chronic diabetes-related complications and mortality in adults with type 1 diabetes: a nationwide cohort study
Kim JY, Kim S, Kim JH
Diabetologia. Pub. Online 21 Mar 2026.
Leggi
Incontri tra esperti: l’attività fisica nel paziente con diabete – webinar 1 aprile
Gentili Soci, nell’ambito delle attività del Gruppo di Studio AMD - SID Diabete e attività fisica, siamo lieti di presentarvi il ciclo di webinar formativi “Incontri tra esperti: l’attività fisica nel paziente con diabete”. L’iniziativa nasce con l’obiettivo di creare uno spazio di confronto dinamico e interattivo tra esperti e soci,…
Leggi
Early tirzepatide use after acute myocardial infarction or ischemic stroke in patients without diabetes: a real-world propensity-matched study
Mortada I, Lee A, Quach V, et al.
Am J Cardiol. Pub. online 18 Mar 2026.
Leggi
Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial
Rosenstock J, Yabe D, Cox D, et al.
Lancet. Pub. online 21 Mar 2026.
Leggi